Xinc OT10 mg

Xinc OT is an oral zinc supplement (zinc bound to orotic acid) used for the following indications:

• Prevention and treatment of zinc deficiency - established use, including deficiency due to inadequate dietary intake, malabsorption syndromes, chronic diarrhea, or increased physiological needs.
• Adjunct nutritional support in conditions associated with increased zinc requirements or losses, such as chronic diarrheal illness, malnutrition, and certain gastrointestinal or malabsorptive disorders, used alongside treatment of the underlying condition.
• Supportive therapy for poor wound healing, hair loss (alopecia), skin conditions, and recurrent infections when these are attributable to documented or clinically suspected zinc deficiency - adjunct use, not a substitute for evaluating the underlying cause.
• Growth and immune support in children with confirmed or suspected zinc deficiency - use guided by a physician.

Xinc OT is not a treatment for conditions unrelated to zinc deficiency, and general claims (e.g., for infertility, sensory disturbances, or mood symptoms) should be regarded as adjunctive at best and are not strongly evidence-supported; a physician should evaluate the underlying cause before long-term use.

Each tablet/capsule of Zinc Orotate contains zinc in the form of zinc orotate, providing a specified amount of elemental zinc (commonly formulated to deliver approximately 5-60 mg elemental zinc per unit dose, depending on the product strength). Excipients vary by manufacturer.

Xinc OT is a mineral (trace element) supplement in which zinc is chelated to orotic acid, a naturally occurring compound that may facilitate zinc transport across cell membranes. Zinc is an essential trace mineral required as a cofactor for over 300 enzymes involved in protein synthesis, immune function, wound healing, DNA synthesis, cell division, growth, and taste/smell perception.

Xinc OT is used as a dietary supplement to prevent or correct zinc deficiency and to provide adjunct nutritional support in states of increased zinc need or loss.

Trace element / mineral supplement (zinc preparation)

Zinc is an essential trace element that serves as a catalytic and structural cofactor for numerous metalloenzymes and transcription factors (zinc-finger proteins). It is required for normal immune cell function (T-lymphocyte and neutrophil activity), wound healing, protein and nucleic acid synthesis, growth and development, and maintenance of taste and smell (gustatory/olfactory function).

In Zinc Orotate, zinc is combined with orotic acid (orotate), which is proposed to improve transport of zinc across cell membranes and enhance intracellular bioavailability compared with some inorganic zinc salts, although comparative clinical evidence for superiority over other zinc salts (e.g., zinc sulfate, zinc gluconate) is limited. Zinc is absorbed primarily in the small intestine via both carrier-mediated and passive diffusion processes; absorption is reduced by phytates, calcium, and iron, and by concurrent food intake to a modest degree.

Take Xinc OT orally, preferably with a meal to reduce the chance of nausea or stomach upset. Swallow the tablet whole with a glass of water. If gastrointestinal upset occurs even with food, consult a physician before adjusting the dose. Avoid taking Xinc OT at the same time as tetracycline or fluoroquinolone antibiotics, or penicillamine; separate dosing by at least 2 hours (see Interactions).

Xinc OT can reduce the absorption and clinical effectiveness of certain oral medications, and its own absorption can likewise be reduced by some agents. Clinically significant interactions include:

• Tetracycline and fluoroquinolone antibiotics (e.g., doxycycline, ciprofloxacin) - zinc chelates with these antibiotics in the gut, reducing absorption of both the antibiotic and zinc. Separate administration by at least 2 hours before or 4-6 hours after the antibiotic dose.
• Penicillamine - zinc can reduce penicillamine absorption and efficacy; separate doses by at least 1-2 hours.
• Copper - chronic zinc supplementation, especially at doses above the tolerable upper intake level, competitively inhibits copper absorption and can precipitate copper deficiency with prolonged use (see Precautions).
• Thiazide diuretics - may increase urinary zinc excretion, potentially lowering zinc levels with long-term co-administration.
• Iron and calcium supplements - high doses taken concurrently may reduce zinc absorption; consider separating dosing times if taken together long-term.

Most patients tolerate Xinc OT well at recommended doses. Reported side effects include:

• Common: Nausea, stomach upset, and mild abdominal discomfort, particularly when taken on an empty stomach.
• Less common: Vomiting, diarrhea or constipation, metallic or unpleasant taste in the mouth, headache.
• With prolonged high-dose use (typically above the tolerable upper intake level): Copper deficiency (which can cause anemia and neurological symptoms), reduced immune function, and lowered HDL cholesterol.

Seek medical advice if side effects are persistent or severe.

Zinc is an essential nutrient required in slightly higher amounts during pregnancy and lactation, and dietary supplementation up to the recommended dietary allowance is generally considered appropriate. However, Xinc OT should be used during pregnancy and breastfeeding only if clearly needed and under medical supervision, since doses above the recommended allowance and tolerable upper intake level have not been established as safe in these populations and could theoretically affect maternal copper and mineral balance. A physician should be consulted before use to confirm the appropriate dose.

Use Xinc OT with the following precautions:

• Copper deficiency risk: Prolonged use of zinc supplementation, particularly at doses exceeding the tolerable upper intake level (40 mg elemental zinc/day for adults), can cause copper deficiency due to competitive inhibition of copper absorption. This may present as anemia or neurological symptoms. Periodic monitoring is reasonable with long-term high-dose use, and copper supplementation may be advised by a physician in such cases.
• Drug absorption interference: May reduce absorption of tetracyclines, fluoroquinolones, and penicillamine (see Interactions) - separate dosing by at least 2 hours.
• Not a substitute for diagnosis: Xinc OT is not a substitute for identifying and treating the underlying cause of suspected zinc deficiency (e.g., malabsorption, chronic disease, dietary insufficiency); underlying conditions should be evaluated by a physician.
• Renal impairment: Patients with significant renal impairment should use zinc supplements only under medical supervision, as zinc excretion may be altered.
• Keep out of reach of children; accidental ingestion of large amounts of zinc-containing products can cause toxicity.

Acute overdose of Xinc OT can cause nausea, vomiting, abdominal cramps, diarrhea, headache, and a metallic taste. Very high acute ingestion may cause fever, lethargy, and gastric bleeding. Chronic excessive intake can lead to copper deficiency, sideroblastic anemia, neutropenia, and neurological impairment. If overdose is suspected, seek immediate medical attention or contact a poison control center; do not attempt to manage a suspected overdose at home without professional guidance.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Elderly: No specific dose adjustment is generally required, but elderly patients should be monitored for gastrointestinal tolerance and, with long-term use, for signs of copper deficiency.

Renal impairment: Use with caution and under medical supervision; zinc handling may be altered in significant renal disease.

Hepatic impairment: No specific well-established dose adjustment; use as directed by a physician.

Pediatric: See Pediatric Uses section.

Duration of Xinc OT therapy depends on the indication. For correction of documented zinc deficiency, treatment is typically continued for several weeks to a few months, with reassessment of zinc status by a physician. For adjunct use in conditions such as chronic diarrhea, treatment duration follows the course of the underlying condition. Long-term, high-dose use beyond what is recommended should be avoided without medical supervision due to the risk of copper deficiency.

Minerals and trace elements; nutritional supplements

Zinc functions as an essential cofactor for more than 300 enzymes and numerous zinc-finger transcription factors, supporting protein and nucleic acid synthesis, cell division, immune cell function, and wound healing. In Zinc Orotate, the orotate carrier is proposed to enhance transport of the zinc ion across cell membranes, improving intracellular delivery compared with some other zinc salts, thereby helping restore normal cellular zinc-dependent processes in deficient states.

Zinc is an essential nutrient in children, and Xinc OT may be used under medical supervision for prevention or treatment of documented zinc deficiency, or as adjunct therapy in conditions such as persistent diarrhea associated with zinc deficiency. Dosing must be individualized by a physician based on the child's age, weight, and indication, and should follow recommended dietary allowance and tolerable upper intake limits for age. Safety and efficacy of specific Xinc OT product formulations have not been separately established for all pediatric age groups, and self-administration in children without medical guidance is not recommended.